On Jan. 21, 2021, Moderna announced that the UKﾒs Medicines and Healthcare products Regulatory Agency (MHRA) had approved its mRNA vaccine against COVID-19 (COVID-19 Vaccine Moderna) for use under Regulation 174. The temporary authorization permitted the supply of COVID-19 Vaccine Moderna in Great Britain and is based upon the advice of the UK Commission on Human Medicines.